Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Fri Oct 21 00:00:00 GMT-04:00 2016
ENLIVEN Phase 3 Study of Pexidartinib in Tenosynovial Giant Cell Tumor (TGCT) Will Continue to Comp ...
PDF (161 KB)
Wed Oct 12 00:00:00 GMT-04:00 2016
Daiichi Sankyo and Dana-Farber Cancer Institute Announce Lung Cancer Research Collaboration
PDF (135 KB)
Tue Oct 11 00:00:00 GMT-04:00 2016
Daiichi Sankyo Announces First Patient Enrolled in Phase 3 QuANTUM-First Trial Investigating Quizar ...
PDF (163 KB)
Sun Oct 09 00:00:00 GMT-04:00 2016
Daiichi Sankyo Presents Late-Breaking Phase 1 Data for Novel Investigational HER2-Targeting Antibod ...
PDF (172 KB)
Tue Oct 04 00:00:00 GMT-04:00 2016
Daiichi Sankyo Announces New Strategic Immuno-Oncology Research Collaboration with AgonOx
PDF (223 KB)
Wed Sep 28 00:00:00 GMT-04:00 2016
Zymeworks and Daiichi Sankyo Announce Immuno-Oncology Cross-Licensing Agreement and Bi-Specific Ant ...
PDF (179 KB)
Tue Sep 27 00:00:00 GMT-04:00 2016
Daiichi Sankyo to Present at ESMO 2016 Late-Breaking Clinical Data for Novel HER2-Targeting Antibod ...
PDF (152 KB)
Tue Sep 06 00:00:00 GMT-04:00 2016
Daiichi Sankyo Announces New Global Head of Development
PDF (295 KB)
Wed Aug 24 00:00:00 GMT-04:00 2016
Data from Phase 3b ENSURE-AF Study Investigating Once-Daily SAVAYSA® (edoxaban) in Patients with At ...
PDF (328 KB)
Thu Aug 18 00:00:00 GMT-04:00 2016
Daiichi Sankyo, Inc. Adds to Its Dynamic Team, Welcoming Leigh Ann Errico as the New Vice President ...
PDF (230 KB)
Showing 21 - 30 of 31 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...